NCT04611087 Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants
| NCT ID | NCT04611087 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Obesity-Related Malignant Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 39 participants |
| Start Date | 2018-07-03 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 39 participants in total. It began in 2018-07-03 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates how individuals feel about a dietary mobile application. Information collected from focus groups and interviews may help doctors and mobile application developers to determine preferences and participant feedback about the appeal and usefulness of a mobile application.
Eligibility Criteria
Inclusion Criteria: * Pasadena Independent School District (ISD) employees who have completed the 6-month Vibrant Lives weight loss program or adults who have completed a weight loss program within the last 12 months
Contact & Investigator
Karen M Basen-Engquist
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT04611087 clinical trial?
This trial is open to participants of all sexes, studying Obesity-Related Malignant Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04611087 currently recruiting?
Yes, NCT04611087 is actively recruiting participants. Contact the research team at kbasenen@mdanderson.org for enrollment information.
Where is the NCT04611087 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT04611087 clinical trial?
NCT04611087 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Karen M Basen-Engquist at M.D. Anderson Cancer Center. The trial plans to enroll 39 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.